Literature DB >> 8666512

[Agreement between information supplied by the patient and a family member on medical history, consumption of tobacco, alcohol and coffee and diet in cancer of the exocrine pancreas and extrahepatic biliary tract].

L Gavaldà1, M Porta, N Malats, J L Piñol, E Fernández, A Maguire, I Cortès, E Carrillo, M Marrugat, J Rifà.   

Abstract

OBJECTIVE: No study on mutations in the K-ras oncogene and cancer of the exocrine pancreas or cancer of the biliary system has analyzed the reliability of clinical and epidemiological information.
METHODS: Agreement between patient and surrogate on factors potentially related to both tumours was evaluated within a multicentre prospective study. Interviews were personally administered to both patient and surrogate (N = 110 pairs). Agreement was examined via the simple kappa index (k), the weighted kappa index (kw), the percentage of simple agreement, and the percentages of positive and negative agreement.
RESULTS: Agreement for medical history was excellent (k between 0.89 and 0.76), as it was for tobacco consumption (k = 0.98). Agreement was moderate for coffee consumption (k = 0.68), frequencies of food groups (kw from 0.66 to 0.38), and consumption of alcoholic drinks (k from 0.66 to 0.32). Surrogates indicated a higher consumption of alcohol than patients.
CONCLUSION: Surrogates can be an alternative source of information when patients cannot be interviewed, but information on alcohol consumption should be treated with caution.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8666512     DOI: 10.1016/s0213-9111(95)71258-4

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  7 in total

1.  Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records. PANKRAS II Study Group.

Authors:  M Soler; N Malats; M Porta; E Fernandez; L Guarner; A Maguire; J L Pinõl; J Rifà; A Carrato
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.

Authors:  M Porta; N Malats; L Guarner; A Carrato; J Rifà; A Salas; J M Corominas; M Andreu; F X Real
Journal:  J Epidemiol Community Health       Date:  1999-11       Impact factor: 3.710

3.  Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage.

Authors:  Miquel Porta; Xavier Fabregat; Núria Malats; Luisa Guarner; Alfredo Carrato; Ana de Miguel; Laura Ruiz; Manuel Jariod; Sergi Costafreda; Susana Coll; Juan Alguacil; Josep M Corominas; Ricard Solà; Antonio Salas; Francisco X Real
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

4.  Timing of blood extraction in epidemiologic and proteomic studies: results and proposals from the PANKRAS II Study.

Authors:  Miquel Porta; José Pumarega; Olga Ferrer-Armengou; Tomàs López; Joan Alguacil; Núria Malats; Esteve Fernàndez
Journal:  Eur J Epidemiol       Date:  2007-07-18       Impact factor: 8.082

5.  Estimating dietary intakes from a brief questionnaire: A simulation study of reliability in a molecular epidemiologic study of pancreatic and biliary diseases.

Authors:  Michelle A Mendez; Jesús Vioque; Miquel Porta; Eva Morales; Tomàs López; Núria Malats; Marta Crous; Luis I Gómez
Journal:  Eur J Epidemiol       Date:  2006-07-08       Impact factor: 8.082

6.  Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer.

Authors:  Eva Morales; Miquel Porta; Jesús Vioque; Tomás López; Michelle A Mendez; José Pumarega; Núria Malats; Marta Crous-Bou; Joy Ngo; Juli Rifà; Alfredo Carrato; Luisa Guarner; Josep M Corominas; Francisco X Real
Journal:  J Epidemiol Community Health       Date:  2007-07       Impact factor: 3.710

7.  Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer.

Authors:  D T Silverman; M Schiffman; J Everhart; A Goldstein; K D Lillemoe; G M Swanson; A G Schwartz; L M Brown; R S Greenberg; J B Schoenberg; L M Pottern; R N Hoover; J F Fraumeni
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.